Table of Contents Table of Contents
Previous Page  4 / 112 Next Page
Show Menu
Previous Page 4 / 112 Next Page
Page Background


NCCN Guidelines for Patients


Prostate Cancer, Version 1.2016


Supported by NCCN Foundation


NCCN Foundation supports the mission of the National Comprehensive Cancer Network




) to

improve the care of patients with cancer. One of its aims is to raise funds to create a library of books for

patients. Learn more about the NCCN Foundation at


National Comprehensive Cancer Network (NCCN)

275 Commerce Drive • Suite 300

Fort Washington, PA 19034


© 2016 National Comprehensive Cancer Network, Inc. All rights reserved.

The NCCN Guidelines for Patients


and illustrations herein may not be reproduced in any form for any

purpose without the express written permission of NCCN.

NCCN aims to improve the care given to patients with cancer. NCCN staff work with experts to create helpful programs and

resources for many stakeholders. Stakeholders include health providers, patients, businesses, and others. One resource is the

series of books for patients called the NCCN Guidelines for Patients


. Each book presents the best practice for a type of cancer.

The patient books are based on clinical practice guidelines written for cancer doctors. These guidelines are called the NCCN

Clinical Practice Guidelines in Oncology (NCCN Guidelines


). Clinical practice guidelines list the best health care options for

groups of patients. Many doctors use them to help plan cancer treatment for their patients.

Panels of experts create the NCCN Guidelines


. Most of the experts are from NCCN Member Institutions. Panelists may include

surgeons, radiation oncologists, medical oncologists, and patient advocates. Recommendations in the NCCN Guidelines are

based on clinical trials and the experience of the panelists. The NCCN Guidelines are updated at least once a year. When funded,

the patient books are updated to reflect the most recent version of the NCCN Guidelines for doctors. For more information about

the NCCN Guidelines, visit


California Prostate Cancer Coalition


CPCC is pleased to endorse

this important resource. We believe

it to be the most understandable and

comprehensive guide for men diagnosed

with prostate cancer who want to really

understand what the disease is about

and what their specific treatment options


Malecare Cancer Support

Malecare Cancer Support group

members know that nothing is more

perplexing than prostate cancer treat-

ment choice making. The NCCN Patient

Guidelines provides an excellent starting

point for discussion, particularly for

African Americans who die from prostate

cancer at twice the rate as Caucasian


National Alliance of State Prostate

Cancer Coalitions (NASPCC)


strongly endorses the NCCN Guidelines

for Patients:

Prostate Cancer, as an

invaluable resource for patients and

others. It is a reliable wealth of important

information about prostate cancer, in a

readable and understandable format.


Today fewer than 47% of men recognize

the lethal consequences of avoiding an

annual prostate examination and blood

test. Guidelines for Patients play a criti-

cal role in our focus to make men – and

the women in their lives – aware of the

need to be pro-active in the fight against

this deadly disease. Breaking down the

“wall of silence” that surrounds men and

prostate cancer is a goal that can be

achieved when men choose to be aware

and take action.



Having a tool that

helps to provide an overview of all the

treatment options available to patients

is critical in winning the fight against

prostate cancer. The NCCN guidelines

aid in this important step.

ZERO - The End of Prostate Cancer

Every 19 minutes a man loses his battle

with prostate cancer. NCCN’s Guidelines

for Patients is a premier resource in

helping men and their families to be pro-

active and make informed decisions. By

advancing research, encouraging action,

and providing educationand support, we

can create Generation ZERO — the first

generation of men free from prostate


NCCN Foundation


gratefully acknowledges: